Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors. [electronic resource]
Producer: 20190624Description: 524-531 p. digitalISSN:- 1940-4034
- Aged
- Angiotensin II Type 1 Receptor Blockers -- adverse effects
- Angiotensin-Converting Enzyme Inhibitors -- adverse effects
- Biomarkers -- blood
- Chelating Agents -- adverse effects
- Drug Interactions
- Europe
- Female
- Humans
- Hyperkalemia -- blood
- Male
- Middle Aged
- Polymers -- adverse effects
- Polypharmacy
- Potassium -- blood
- Prospective Studies
- Renin-Angiotensin System -- drug effects
- Risk Factors
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.